Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.66
0.02 (1.22%)
At close: Oct 03, 2025, 3:59 PM
1.67
0.60%
After-hours: Oct 03, 2025, 06:35 PM EDT
1.22% (1D)
| Bid | 1.57 |
| Market Cap | 123.7M |
| Revenue (ttm) | 26.27K |
| Net Income (ttm) | -41.5M |
| EPS (ttm) | -0.04 |
| PE Ratio (ttm) | -41.5 |
| Forward PE | -2.88 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 1.71 |
| Volume | 65,812 |
| Avg. Volume (20D) | 122,631 |
| Open | 1.65 |
| Previous Close | 1.64 |
| Day's Range | 1.57 - 1.70 |
| 52-Week Range | 1.15 - 4.20 |
| Beta | 0.90 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for IKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10 months ago
-13.14%
Inhibikase Therapeutics shares are trading lower. ...
Unlock content with
Pro Subscription
11 months ago
+3.6%
Inhibikase Therapeutics shares are trading higher after Jefferies initiated coverage on the stock with a Buy rating and announced an $8 price target.
